Clinical study on Vasa Kantkari Kwath in the management of Shwasa (Bronchial Asthma) in children
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 10
- 试验地点
- 1
- 主要终点
- Primarily the improvement in the patient will be assessed mainly based on certain symptoms of the disease- Kasa (Cough), Shwasakrichchhata (Dyspnea), Ghurghuraka (Wheezing), Use of Accessory Muscles (Sternomastoid Activity), Nidralpata (Disturbance in Sleep),Bhasana kricchthta (Difficulty in Speaking), Nasal Discharge, Colour of Face will be assessed before treatment and after treatment on subsequent 7th day, 15th day, 30th day.
研究概览
简要总结
To explore clinical effectiveness of Vasa kantakari kwath in alleviating symptoms associated with shwasa in children .
Study design is Single Arm Open Label. Duration of study will be 30 days for eligible 10 patients on the basis of inclusion criteria and symptoms will be assessed before and after treatment.
It will be given through oral route, and dosage will be decided on the basis of Young’s formula according to age of child.
研究设计
- 研究类型
- Interventional
- 分配方式
- Other
- 盲法
- None
入排标准
- 年龄范围
- 5.00 Year(s) 至 12.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Individual between age group of 5 to 12 years of both sexes.
- •2.All the case of both sexes, cast, and religion will be included in the study.
- •3.Children diagnosed as shwasa as per contemporary medical sciences as per clinical features mentioned in Ayurvedic texts.
- •4.Children with no family history of bronchial asthma.
排除标准
- •1.Children below 5 and above 12 years of age.
- •2.Patients suffering from chronic respiratory disorders like pulmonary tuberculosis, chronic lung disease, pulmonary edema, lung carcinoma will be excluded from present study.
- •Patient suffering from cardiac disease, chronic pulmonary disorders like tuberculosis, bronchiectasis, chronic lung disease, bronchogenic carcinoma etc will be excluded from study.
结局指标
主要结局
Primarily the improvement in the patient will be assessed mainly based on certain symptoms of the disease- Kasa (Cough), Shwasakrichchhata (Dyspnea), Ghurghuraka (Wheezing), Use of Accessory Muscles (Sternomastoid Activity), Nidralpata (Disturbance in Sleep),Bhasana kricchthta (Difficulty in Speaking), Nasal Discharge, Colour of Face will be assessed before treatment and after treatment on subsequent 7th day, 15th day, 30th day.
时间窗: 7th, 15th, 30th day
次要结局
- To investigate the impact of Vasa Kantakari Kwath on the frequency & severity of recurrent shwasa episodes in children.(To assess the effect of therapy, certain symptoms will be given scoring depending upon their severity.)
研究者
Darshana Jain
Post Graduate Institute Of Ayurved DSRRAU Jodhpur